The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A systematic review of anti-suicidal effects of sedative-hypnotics and cognitive behavioral therapy for insomnia
Open accessAbstract
Suicide accounts for over 700,000 deaths per year globally and remains a public health priority. Evidence suggests that sleep-related interventions may be effective in reducing depressive symptom severity and suicidal thoughts in patients diagnosed with depression and comorbid insomnia. This study aims to systematically review the efficacy of sedative-hypnotics and/or cognitive behavioral therapy for insomnia (CBT-I) on measures of suicidality. In accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, PubMed, Medline, Cochrane Library, Embase, Scopus, and Web of Science were searched from inception to July 30, 2024. Studies were included if they (1) were randomized controlled trials (RCTs) and (2) reported on suicide-related measures associated with sleep interventions as a primary outcome, secondary outcome, or a safety measure. We endeavored to define and operationalize suicidality as suicidal ideation (SI), suicide attempts (SA), and suicide completion (SC). In cases where study authors failed to separate these three dimensions, the term “suicidality” was applied. Eighteen studies were identified meeting inclusion criteria, comprised of studies investigating benzodiazepines ( n = 2), Z-drugs ( n =4), orexin receptor antagonists (ORAs) ( n =8), and CBT-I ( n =4). Zolpidem reduces SI as well as insomnia (linear association = 0.12, p <0.05) as evidenced by improvement on both the Columbia-Suicide Severity Rating Scale (C-SSRS) and the Scale for Suicide Ideation (SSI). ORAs were not associated with either an increase or decrease in suicidality. CBT-I alleviates SI in patients with insomnia ( t = −3.35, p <0.05). Effectively treating insomnia is associated with reduced SI. Available evidence suggests that Food and Drug Administration (FDA)-approved sedative-hypnotics do not increase the risk of suicidality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Clinical sleep interventions can reduce insomnia and may improve mood or suicidal ideation, but these findings should not be taken as direct evidence for GIRK-targeted antidepressant efficacy [324,325,326].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 21
- 10.1016/j.jpsychires.2020.12.038 · DOI · Paper page
- 10.3389/fpsyt.2021.676962 · DOI
- 10.1192/bjpo.bp.117.005231 · DOI
- 10.1016/j.cpr.2020.101895 · DOI · Paper page
- 10.1016/S0140-6736(22)00878-9 · DOI · Paper page
- 10.1080/14728214.2025.2452514 · DOI
- 10.1111/jsr.14133 · DOI
- 10.1016/j.jadohealth.2021.11.005 · DOI
- 10.3390/jcm9113492 · DOI
- 10.1016/j.biopsych.2006.01.016 · DOI · Paper page
- 10.1016/j.biopsych.2016.04.018 · DOI
- 10.1016/S0165-0327(01)00352-4 · DOI
- 10.1007/s40273-021-01019-4 · DOI · Paper page
- 10.1016/j.biopsych.2014.10.003 · DOI · Paper page
- Page, 2021, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372
- 10.5664/jcsm.8508 · DOI
- 10.1016/j.sleep.2024.07.037 · DOI
- 10.1002/da.22776 · DOI · Paper page
- 10.1001/jamanetworkopen.2019.18254 · DOI · Paper page
- 10.1016/j.smrv.2022.101597 · DOI · Paper page
- 10.1080/14740338.2024.2430306 · DOI
Cited by
Olten, B., Unlu, H., Sharma, M., & McCall, W. V. (2026) · Current Sleep Medicine Reports · doi:10.1007/s40675-026-00358-y · Cited by 1
“…the anti-suicidal effects of sedative-hypnotics and cognitive-behavioral therapy for insomnia, which similarly emphasized the moderating roles of baseline suicidality, insomnia severity, and insomnia symptom improvement in shaping suicide-related outcomes following insomnia treatment [ 34].”
Sun, N., Chu, H., Tang, Q., Yu, X., Li, L., Fang, B., Han, B., Fu, Y., & Chang, H. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121769 · Cited by 1
Guo, W., Zhang, C., Yang, R., & Liang, Y. (2025) · Medicine · doi:10.1097/md.0000000000044797 · Cited by 1
“[25,26] The evidence shows zolpidem’s intrinsic suicide risk while highlighting its therapeutic potential in targeted populations, making it an ideal comparator for evaluating BZD-related suicide risks.”
Romier, A., Leseur, J., Moroy, A., & Geoffroy, P. A. (2026) · L Encéphale · doi:10.1016/j.encep.2026.03.004 · Cited by 3
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Valentino, K., Teopiz, K., Wong, S., Le, G. H., Badulescu, S., Johnson, D., Ho, R., Rhee, T. G., Cao, B., Rosenblat, J., Mansur, R., & McIntyre, R. S.
- Affiliations
- University Health Network (CA)
- Brain and Cognition Discovery Foundation (CA)
- National University of Singapore (SG)
- University of Connecticut (US)
- Southwest University (CN)
- University of Toronto (CA)
- Corresponding author
- McIntyre, Roger S.
- ORCID
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2025
- Volume
- 30
- Issue
- 1
- Pages
- e45-e45
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- PMC
- PMC13064792
- OpenAlex
- W4410968328
- Cited by
- 12
- References
- 0
- Citations by year
- 2026: 10 · 2025: 2
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- CNS Spectrums (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- suicidality, suicidal ideation, suicide attempts, suicide completion, sedative-hypnotic drugs, cognitive behavioral therapy for insomnia, insomnia, depression, benzodiazepines, Z-drugs, zolpidem, orexin receptor antagonists, sleep interventions, suicide risk
- MeSH terms
- Suicide Prevention, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy, Suicidal Ideation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic review of anti-suicidal effects of sedative-hypnotics and cognitive behavioral therapy for insomnia. https://app.cochat.ai/papers/10.1017/s1092852925000318
- The paper
- Valentino, K., Teopiz, K., Wong, S., Le, G. H., Badulescu, S., Johnson, D., Ho, R., Rhee, T. G., Cao, B., Rosenblat, J., Mansur, R., & McIntyre, R. S. (2025). A systematic review of anti-suicidal effects of sedative-hypnotics and cognitive behavioral therapy for insomnia. CNS Spectrums. https://doi.org/10.1017/s1092852925000318
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
